[ad_1]
The global market for respiratory inhalation devices is expected to reach $ 43,214.0 million by the end of 2025.
This press release was originally distributed by SBWire
Valley Cottage, NY – (SBWIRE) – 10/30/2018 – Future Market Insights (FMI) provides vital information on the global market for respiratory inhalation devices in its forthcoming edition entitled "The Market for Medical Devices". Respiratory Inhalation: Sector Analysis Opportunity Assessment, 2015 – 2025 ". In terms of value, the global market for respiratory inhalers is expected to post a healthy CAGR of 4.3% over the forecast period due to a variety of factors. This IMF report provides essential and detailed information on these factors.
The market for respiratory inhalation devices is segmented by product type, disease indications, technology and region. Based on the segmentation of the product, the global market was classified as MDI, DPI and nebulizer.
The nebulizers are further subdivided into ultrasonic nebulizer, mesh nebulizer and compressed air nebulizer. It is estimated that the MDI segment represents a maximum share of the global market for respiratory inhalers by the end of 2015 and is expected to have a CAGR of 4.5% in value over the 2015-2025 forecast period. . Currently, the metered dose inhaler is a major contributor to market growth in Europe, North America and parts of Asia-Pacific. The demand for nebulizers is expected to grow at a CAGR of 3.8% by 2025.
For key findings Request a sample report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-493
The increase in the prevalence of asthma, COPD and other respiratory disorders, particularly among the pediatric and geriatric population, is one of the main drivers of market growth. global respiratory inhalation devices. Other key factors include strategic alliances among key market players, manufacturers seeking to strengthen their market share and expansion of the health sector in developing countries through increased investment from key players. In addition, the increased demand for respiratory inhalers in all conditions of acute and moderate asthma and COPD due to increased health awareness and increase in disposable income is expected to result in an increase in expenditure on respiratory inhalers. This should in turn strengthen the growth of the respiratory inhalation device market over the forecast period.
Browse the entire "Respiratory Inhalation Devices Market: Global Sector Analysis and Opportunity Assessment, Reports 2015 – 2025" at https://www.futuremarketinsights.com/reports/ respiratory-inhale-devices-market
The lack of effective medications for certain respiratory disorders, concerns about side effects and complications, lack of qualified respirologists and health professionals, lack of patient awareness and high prices of inhalation devices are the main factors that hinder the growth of this market.
Currently, combination therapies offer more associated benefits, such as reliability, increased efficiency, and favorable reimbursement policies. Because of these factors, patients with complex respiratory disorders are more likely to adopt such treatments.
However, the cost associated with combination therapies is higher than that of conventional therapies for patients with complex respiratory disorders. The global market for respiratory inhalation devices is expected to be fueled by the increasing use of newly introduced triple therapy for COPD patients over the next few years.
This report assesses the trends underlying each segment and provides analysis and information on the market potential of respiratory inhalation devices in specific regions. North America is expected to dominate the market for respiratory inhalation devices with a maximum market share by the end of 2015. North America and Europe's West should collectively account for more than 64.1% of the total market share of respiratory inhalation devices in value by the end of 2015. The CAGR is estimated to be the highest ( 5.0%) over the forecast period, followed by North America, due to the increasing prevalence of asthma and COPD among children and the geriatric population.
Report Methodology Request @: https://www.futuremarketinsights.com/askus/rep-gb-493
AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Cipla Ltd., Koninklijke Philips NV, PARI Medical Holding, Teva Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Ltd., OMRON Healthcare Europe BV and Merck & Co., are among the leading companies covered in the this report. Inc.
Their main objective is to improve their product portfolio through research and development, to introduce innovative and cost-effective medicines and medical devices in order to gain market share and strengthen their respective positions in the global market.
For more information on this press release, visit: http://www.sbwire.com/press-releases/increasing-prevalence-of-asthma-and-copd-fuelling-demand-for-respiratory-inhaler -devices-1075877.htm
[ad_2]
Source link
